The best-in-class BrightInsight Platform accelerates the time to market for patient apps that enable biopharma companies to differentiate their therapies and enhance the patient journey. Read...
Read MoreSAN JOSE, Calif. and SALT LAKE CITY, Sept. 21, 2022 (GLOBE NEWSWIRE) — BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions and bioMérieux, a world leader in the field of in vitro diagnostics, announced today a partnership to develop and bring to market a Clinical Digital Solution for diagnostics enabling clinical decision support for disease areas across their diagnostic tests. Read...
Read MoreDigital health is facing some serious headwinds. Examples of successful digital health programs with demonstrable return on investment (ROI) exist, but they’re scarce. As we enter the Digital Health 3.0 era, that’s led to a great degree of skepticism about digital health’s promise. Read...
Read MoreSAN JOSE, Calif., March 20, 2023 (GLOBE NEWSWIRE) — BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today that the company has been named to Fierce Medtech’s 2022 Fierce 15. Read...
Read MoreSAN JOSE, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) — BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today from DTx West, that ixlayer is the latest partner to join the BrightInsight Ecosystem, a network of more than 20 of the world’s leading healthcare and technology companies driving growth and adoption of digital health solutions. Read...
Read More
